|
It was reported that during an elective transfemoral carotid artery stenting procedure, the operator applied "extreme pressure" of th cguard prime stent delivery system to deploy the stent.The stent was able to be deployed successfully, however the stent was deployed covering a portion of the lesion.A secondary inspiremd stent was used to cover the lesion and the procedure was completed without any patient harm.
|
|
This mdr is being submitted retrospectively as part of capa-us-002-26, identified during a retrospective review conducted under the capa.See related importer report # 3032814119-2025-00007.Device investigation: the device was not returned to insiremd for physical analysis, however, the product history review confirmed the device met all manufacturing specifications, with no malfunction or nonconformance identified.The procedure was completed successfully, and no patient harm or adverse clinical outcome was reported.An investigation was initiated to identify the underlying failure mode(s) associated with delivery system deployment complications which may result in high resistance or inability to deploy the stent.Capa-027-25 has been initiated to further evaluate similar field-reported performance issues, and complaint trending activities remain ongoing.In response to the reported deployment-related incident, an investigation was initiated to identify the underlying failure mode(s) associated with delivery system deployment difficulties.A related product recall (recall no.Z-2330-2026) was initiated on may 02, 2026 affecting all 135cm carotid stent systems.All findings and resulting actions will be documented in accordance with established quality system procedures, and updates will be submitted as required.
|